AltrixBio

0 followers


AltrixBio is an early-stage company focused on advancing our lead platform: LuCI™ AJN 003, an oral drug that replicates the metabolic success of bariatric surgery in treated of Type 2 Diabetes.

Industries

Headquarters

Stage

Employees

Links

Org chart

Nancy Briefs
Co-Founder, President & CEO

Nancy Briefs

Collapse
Jay L. Warner
Acting SVP Of Business Development